ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

Tumor Size Predicts Survival In Early-Stage Lung Cancer

November 28, 2003

NCI Considering Master Agreements For Cancer Centers

August 2, 1991

President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget

February 5, 1999

In Brief: Fred Rapp to Retire, Set Sail For Europe; Armand Hammer To Celebrate 92nd Birthday

May 18, 1990

NCI Plans To Issue Frederick Operations Contract As Sole-Source To SAIC-Frederick Inc. For Up To 10 Years.

November 10, 2006